Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million
03/08/2023 14:49
Paratek Pharmaceuticals Inc PRTK.O :
* PARATEK PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2023
REVENUE OF
$40.0 MILLION
* Q2 REVENUE $40.0 MILLION VERSUS $29.6 MILLION
* Q2 LOSS PER SHARE $0.25
* CASH AND CASH EQUIVALENTS OF $42.7 MILLION AS OF JUNE 30,
2023
* Q2 EARNINGS PER SHARE VIEW $-0.31, REVENUE VIEW $33.9
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXb3BdKw
Further company coverage: PRTK.O
Recent news on Paratek Pharmaceuticals
See all newsNovo Holdings closes $462 mln acquisition of Paratek Pharmaceuticals
Brief: Glass Lewis Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Responds to Demand Letters From 11 Stockholders Alleging 'Misleading', Incomplete Statements In Proxy Statement Filed On June 30
Brief: Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote For Acquisition By Gurnet Point Capital And Novo Holdings
Brief: Paratek Pharmaceuticals Announces Second Quarter 2023 Revenue Of $40.0 Million